Trillium Therapeutics' Unattributed VC Round

Trillium Therapeutics raised a round of funding on May 12, 2011.

Trillium Therapeutics is a research and development company developing therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses, includin…

Articles about Trillium Therapeutics' Unattributed VC Round: